Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study.
atherosclerosis
eHealth
mHealth
medication adherence
patient acceptance of health care
patient-centered care
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
14 03 2019
14 03 2019
Historique:
received:
21
05
2018
accepted:
26
10
2018
revised:
25
10
2018
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
15
3
2019
Statut:
epublish
Résumé
Cardiovascular disease, including atherosclerotic cardiovascular disease (ASCVD), is a growing public health threat globally and many individuals remain undiagnosed, untreated, and uncontrolled. Simultaneously, mobile health (mHealth) interventions using short messaging service (SMS) have gained popularity globally. There is an opportunity for innovative approaches such as mHealth to encourage and enable adherence to medications for ASCVD and its risk factors. This study aimed to understand mobile technology acceptance, use, and facilitating conditions among the study population ahead of the design of an mHealth intervention. Using data from a mixed-methods study conducted in Singapore, we conducted a cross-sectional survey with 100 participants and in-depth, semistructured interviews with 20 patients. All participants were over the age of 40 years with ASCVD or its risk factors. Interviews were conducted in English and Mandarin and if needed translated to English. Nvivo 11 (QSR International) was used for analyses. Participants reported their perspectives on technology use and preferences, including low or sporadic mobile phone use and usability concerns including small screen and text size, among others; the benefit of previous mHealth use in creating a favorable opinion of SMS for health information; trust in both the source of mHealth SMS, as well as in treatment; the formation of habits; and fear of sequelae or death for facilitating intention to use an mHealth intervention and adhere to medication. We also highlighted a case that underscored the importance of the period after diagnosis in habit forming as an opportunity for an mHealth intervention. We explored both technology- and adherence-related factors that influence a patient's intention to use an mHealth intervention for adherence to ASCVD medication in Singapore. We highlighted the importance of identifying the right opportunity to engage with patients and promote an mHealth intervention for adherence, such as immediately following diagnosis when patients are establishing medication-taking habits.
Sections du résumé
BACKGROUND
Cardiovascular disease, including atherosclerotic cardiovascular disease (ASCVD), is a growing public health threat globally and many individuals remain undiagnosed, untreated, and uncontrolled. Simultaneously, mobile health (mHealth) interventions using short messaging service (SMS) have gained popularity globally. There is an opportunity for innovative approaches such as mHealth to encourage and enable adherence to medications for ASCVD and its risk factors.
OBJECTIVE
This study aimed to understand mobile technology acceptance, use, and facilitating conditions among the study population ahead of the design of an mHealth intervention.
METHODS
Using data from a mixed-methods study conducted in Singapore, we conducted a cross-sectional survey with 100 participants and in-depth, semistructured interviews with 20 patients. All participants were over the age of 40 years with ASCVD or its risk factors. Interviews were conducted in English and Mandarin and if needed translated to English. Nvivo 11 (QSR International) was used for analyses.
RESULTS
Participants reported their perspectives on technology use and preferences, including low or sporadic mobile phone use and usability concerns including small screen and text size, among others; the benefit of previous mHealth use in creating a favorable opinion of SMS for health information; trust in both the source of mHealth SMS, as well as in treatment; the formation of habits; and fear of sequelae or death for facilitating intention to use an mHealth intervention and adhere to medication. We also highlighted a case that underscored the importance of the period after diagnosis in habit forming as an opportunity for an mHealth intervention.
CONCLUSIONS
We explored both technology- and adherence-related factors that influence a patient's intention to use an mHealth intervention for adherence to ASCVD medication in Singapore. We highlighted the importance of identifying the right opportunity to engage with patients and promote an mHealth intervention for adherence, such as immediately following diagnosis when patients are establishing medication-taking habits.
Identifiants
pubmed: 30869651
pii: v7i3e11108
doi: 10.2196/11108
pmc: PMC6437612
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e11108Informations de copyright
©Victoria Haldane, Yao Guo Tan, Krichelle Wei Qi Teo, Joel Jun Kai Koh, Aastha Srivastava, Rui Xiang Cheng, Yi Cheng Yap, Pei-Shi Ong, Rob M van Dam, Jie Min Foo, Falk Müller-Riemenschneider, Gerald Choon-Huat Koh, Pablo Perel, Helena Legido-Quigley. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 14.03.2019.
Références
EXCLI J. 2013 May 13;12:413-36
pubmed: 26417235
Int J Med Inform. 2016 Jun;90:22-31
pubmed: 27103194
J Diabetes Res. 2016;2016:1604609
pubmed: 27034957
Oncotarget. 2017 Feb 16;8(34):57477-57488
pubmed: 28915687
JMIR Diabetes. 2017 Jan 23;2(1):e2
pubmed: 30291051
Cochrane Database Syst Rev. 2017 Apr 29;4:CD011851
pubmed: 28455948
PLoS One. 2011 Jan 20;6(1):e16395
pubmed: 21283719
Ann Fam Med. 2014 May-Jun;12(3):224-32
pubmed: 24821893
Soc Sci Med. 2009 Mar;68(6):1060-8
pubmed: 19162386
AMIA Annu Symp Proc. 2014 Nov 14;2014:1920-9
pubmed: 25954465
Am J Trop Med Hyg. 2011 Jul;85(1):26-33
pubmed: 21734120
PLoS Med. 2006 Sep;3(9):e344
pubmed: 16953660
Ethn Health. 2014;19(5):565-78
pubmed: 24266617
Health Expect. 2012 Dec;15(4):339-50
pubmed: 21348905
Heart Lung. 2008 Jan-Feb;37(1):8-16, 16.e1
pubmed: 18206522
PLoS One. 2015 Apr 24;10(4):e0122112
pubmed: 25909595
Lancet. 1976 Jun 12;1(7972):1265-8
pubmed: 73694
Stud Health Technol Inform. 2015;216:467-71
pubmed: 26262094
BMJ Open. 2015 Nov 02;5(11):e007574
pubmed: 26525717
J Nutr Educ Behav. 2015 Jan-Feb;47(1):75-80
pubmed: 25282200
Pediatr Pulmonol. 2010 Feb;45(2):157-64
pubmed: 20054860
Int J Cardiol. 2015 Dec;201 Suppl 1:S1-7
pubmed: 26747389
Glob Heart. 2015 Jun;10(2):99-110
pubmed: 26213297
Front Public Health. 2013 Dec 05;1:66
pubmed: 24350234
Value Health. 2014 Nov;17(7):A400
pubmed: 27200951
BMJ Open. 2015 Nov 17;5(11):e009367
pubmed: 26576813
BMC Fam Pract. 2015 Jul 03;16:80
pubmed: 26137844